TCGACOAD test cohort | Independent validation cohort | |
---|---|---|
(n = 240) | (n = 60) | |
Gender | ||
Male | 132 | 38 |
Female | 108 | 22 |
Age | ||
60 years or younger | 82 | 22 |
Older than 60 years | 158 | 38 |
TNM stage | ||
I | 39 | 10 |
II | 93 | 15 |
III | 75 | 28 |
IV | 33 | 7 |
Pathologic M stage | ||
M0 | 207 | 53 |
M1 | 33 | 7 |
Nodes count | ||
12 or more | 189 | 19 |
Less than 12 | 51 | 41 |
Lymphatic invasion | ||
Absent | 166 | 25 |
Present | 74 | 35 |
Vascular Invasion | ||
Absent | 193 | 47 |
Present | 47 | 13 |
Follow-up time (months) | ||
Median | 13.367 | 33 |
Range | (0.067–141.1) | (4.0–57.0) |
Preoperative serum CEA level | ||
<5 μg/mL | 188 | 37 |
≥5 μg/mL | 52 | 23 |